Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1461-1470 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|November 16, 2005
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillanceDori A Thomas, Joan Massagué
Cancer Cell|November 16, 2005
Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenanceKian-Huat Lim, Christopher M Counter
Cancer Cell|November 16, 2005
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionSooryanarayana Varambally, Jianjun Yu, Bharathi Laxman, et al.
Cancer Cell|December 10, 2014
Epigenetic noise fuels cancer evolutionCharles Swanton, Stephan Beck
Cancer Cell|December 10, 2014
DOTting the path to doom: how acceleration of histone methylation leads to leukemiaChristian Bach, Robert K Slany
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cancer Cell|December 10, 2014
Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growthKshitij Srivastava, Junhao Hu, Claudia Korn, et al.
Cancer Cell|January 14, 2015
Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacyEsther Bridges, Adrian L Harris
Cancer Cell|January 14, 2015
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancerAnja Lux, Falk Nimmerjahn
Cancer Cell|December 18, 2014
ChIP-ping away at EWS/ETS transcription networksChristopher T Denny
Pageof 383

Showing results (1461-1470 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|November 16, 2005
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillanceDori A Thomas, Joan Massagué
Cancer Cell|November 16, 2005
Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenanceKian-Huat Lim, Christopher M Counter
Cancer Cell|November 16, 2005
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionSooryanarayana Varambally, Jianjun Yu, Bharathi Laxman, et al.
Cancer Cell|December 10, 2014
Epigenetic noise fuels cancer evolutionCharles Swanton, Stephan Beck
Cancer Cell|December 10, 2014
DOTting the path to doom: how acceleration of histone methylation leads to leukemiaChristian Bach, Robert K Slany
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cancer Cell|December 10, 2014
Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growthKshitij Srivastava, Junhao Hu, Claudia Korn, et al.
Cancer Cell|January 14, 2015
Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacyEsther Bridges, Adrian L Harris
Cancer Cell|January 14, 2015
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancerAnja Lux, Falk Nimmerjahn
Cancer Cell|December 18, 2014
ChIP-ping away at EWS/ETS transcription networksChristopher T Denny
Pageof 383